Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01655498 · ClinicalTrials.gov registry record · NA
A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE)
A NA study, sponsored by Pelvalon.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT01655498 is a NA study that has completed, run by Pelvalon. The registered enrollment target is 61 participants.
The verdict
NCT01655498, a NA study, has completed, sponsored by Pelvalon.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of this study is to obtain preliminary efficacy and safety data on the use of the LivSure System (now called the "Eclipse™ System") in women with fecal incontinence.
Interventions
- DEVICE vaginal bowel control system (LivSure)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01655498
The ClinicalTrials.gov registry entry for NCT01655498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pelvalon, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vaginal bowel control system (LivSure) is the first listed.
NCT01655498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01655498 about?
NCT01655498 is a clinical study titled "A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE)". The objective of this study is to obtain preliminary efficacy and safety data on the use of the LivSure System (now called the "Eclipse™ System") in women with fecal incontinence.
What is the current status of trial NCT01655498?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2012-08. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01655498?
The interventions under investigation include: vaginal bowel control system (LivSure) (DEVICE).
Who is sponsoring clinical trial NCT01655498?
This trial is sponsored by Pelvalon, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.